Skip Navigation


Human Molecular Genetics Advance Access originally published online on April 28, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/12/1241    most recent
ddh135v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (65)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hussain, S.
Right arrow Articles by Mathew, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hussain, S.
Right arrow Articles by Mathew, C. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 12 1241-1248
DOI: 10.1093/hmg/ddh135
Human Molecular Genetics, Vol. 13, No. 12 © Oxford University Press 2004; all rights reserved

Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways

Shobbir Hussain1, James B. Wilson2, Annette L. Medhurst3, James Hejna4, Emily Witt5, Sahana Ananth2, Adelina Davies6, Jean-Yves Masson7, Robb Moses4, Stephen C. West6, Johan P. de Winter3, Alan Ashworth5, Nigel J. Jones2 and Christopher G. Mathew1,*

1Division of Genetics and Development, Guy's, King's and St Thomas's School of Medicine, King's College London, London, UK, 2School of Biological Sciences, University of Liverpool, Liverpool, UK, 3Department of Clinical Genetics and Human Genetics, Free University Medical Centre, Amsterdam, The Netherlands, 4Oregon Health Sciences University, Portland, OR, USA, 5The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK, 6Cancer Research UK London Research Institute, Clare Hall Laboratories, Hertfordshire, UK and 7Laval University Cancer Research Center, Quebec City, Quebec, Canada

Received February 6, 2004; Revised April 5, 2004; Accepted April 19, 2004

Fanconi anaemia (FA) is a chromosomal instability disorder characterized by cellular sensitivity to DNA interstrand crosslinking agents and a high risk of cancer. Six of the eight proteins encoded by the known FA genes form a nuclear complex which is required for the monoubiquitination of the FANCD2 protein. FANCD2 complexes and colocalizes with BRCA1, but its presumptive role in DNA repair has not yet been clearly defined. We used yeast two-hybrid analysis to test for interaction between FANCD2 and 10 proteins involved in homologous recombination repair. FANCD2 did not interact with RAD51, the five RAD51 paralogs, RAD52, RAD54 or DMC1. However, it bound to a highly conserved C-terminal site in BRCA2 that also binds FANCG/XRCC9. FANCD2 and BRCA2 can be coimmunoprecipitated from cell extracts of both human and Chinese hamster wild-type cells, thus confirming that the interaction occurs in vivo. Formation of nuclear foci of FANCD2 was normal in the BRCA2 mutant CAPAN-1 cells, which indicates that the recruitment of FANCD2 to sites of DNA-repair is independent of wild-type BRCA2 function. FANCD2 colocalized with RAD51 in foci following treatment with mitomycin C or hydroxyurea, and colocalized very tightly with PCNA after treatment with hydroxyurea. These findings suggest that FANCD2 may have a role in the cellular response to stalled replication forks or in the repair of replication-associated double-strand breaks, irrespective of the type of primary DNA lesion.

* To whom correspondence should be addressed at: Division of Genetics and Development GKT, 8th Floor, Guy's Tower, Guy's Hospital, London SE1 9RT, UK. Tel: +44 2071883721; Fax: +44 2071882585; Email: christopher.mathew{at}genetics.kcl.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Hejna, M. Holtorf, J. Hines, L. Mathewson, A. Hemphill, M. Al-Dhalimy, S. B. Olson, and R. E. Moses
Tip60 Is Required for DNA Interstrand Cross-link Repair in the Fanconi Anemia Pathway
J. Biol. Chem., April 11, 2008; 283(15): 9844 - 9851.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Kenyon and S. L. Gerson
The role of DNA damage repair in aging of adult stem cells
Nucleic Acids Res., December 26, 2007; (2007) gkm1064v1.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
Y. Nomura, N. Adachi, and H. Koyama
Human Mus81 and FANCB independently contribute to repair of DNA damage during replication
Genes Cells, October 1, 2007; 12(10): 1111 - 1122.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Oda, T. Hayano, H. Miyaso, N. Takahashi, and T. Yamashita
Hsp90 regulates the Fanconi anemia DNA damage response pathway
Blood, June 1, 2007; 109(11): 5016 - 5026.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. K. Nookala, S. Hussain, and L. Pellegrini
Insights into Fanconi Anaemia from the structure of human FANCE
Nucleic Acids Res., March 12, 2007; 35(5): 1638 - 1648.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. Weber, Y. Xu, L. Zhang, A. Patocs, L. Shen, P. Platzer, and C. Eng
Microenvironmental Genomic Alterations and Clinicopathological Behavior in Head and Neck Squamous Cell Carcinoma
JAMA, January 10, 2007; 297(2): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Gallmeier and S. E. Kern
Targeting Fanconi Anemia/BRCA2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models
Clin. Cancer Res., January 1, 2007; 13(1): 4 - 10.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Wang, T. Wiltshire, J. Senft, S. L. Wenger, E. Reed, and W. Wang
Fanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
Mol. Cancer Ther., December 1, 2006; 5(12): 3153 - 3161.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Pejovic, J. E. Yates, H. Y. Liu, L. E. Hays, Y. Akkari, Y. Torimaru, W. Keeble, R. K. Rathbun, W. H. Rodgers, A. E. Bale, et al.
Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
Cancer Res., September 15, 2006; 66(18): 9017 - 9025.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
S. Tremblay, P. Pintor dos Reis, G. Bradley, N. N. Galloni, B. Perez-Ordonez, J. Freeman, D. Brown, R. Gilbert, P. Gullane, J. Irish, et al.
Young Patients With Oral Squamous Cell Carcinoma: Study of the Involvement of GSTP1 and Deregulation of the Fanconi Anemia Genes.
Arch Otolaryngol Head Neck Surg, September 1, 2006; 132(9): 958 - 966.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Barroso, R.L. Milne, L.P. Fernandez, P. Zamora, J.I. Arias, J. Benitez, and G. Ribas
FANCD2 associated with sporadic breast cancer risk
Carcinogenesis, September 1, 2006; 27(9): 1930 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. McCabe, N. C. Turner, C. J. Lord, K. Kluzek, A. Bialkowska, S. Swift, S. Giavara, M. J. O'Connor, A. N. Tutt, M. Z. Zdzienicka, et al.
Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition
Cancer Res., August 15, 2006; 66(16): 8109 - 8115.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi and A. D. D'Andrea
Molecular pathogenesis of Fanconi anemia: recent progress
Blood, June 1, 2006; 107(11): 4223 - 4233.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. A. McAllister, C. D. Houle, J. Malphurs, T. Ward, N. K. Collins, W. Gersch, L. Wharey, J. C. Seely, L. Betz, L. M. Bennett, et al.
Spontaneous and Irradiation-Induced Tumor Susceptibility in Brca2 Germline Mutant Mice and Cooperative Effects with a p53 Germline Mutation
Toxicol Pathol, February 1, 2006; 34(2): 187 - 198.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Sobeck, S. Stone, V. Costanzo, B. de Graaf, T. Reuter, J. de Winter, M. Wallisch, Y. Akkari, S. Olson, W. Wang, et al.
Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks
Mol. Cell. Biol., January 15, 2006; 26(2): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. D. Kennedy and A. D. D'Andrea
The Fanconi Anemia/BRCA pathway: new faces in the crowd
Genes & Dev., December 15, 2005; 19(24): 2925 - 2940.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Houghtaling, A. Newell, Y. Akkari, T. Taniguchi, S. Olson, and M. Grompe
Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining
Hum. Mol. Genet., October 15, 2005; 14(20): 3027 - 3033.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y.-G. Yang, Z. Herceg, K. Nakanishi, I. Demuth, C. Piccoli, J. Michelon, G. Hildebrand, M. Jasin, M. Digweed, and Z.-Q. Wang
The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells
Carcinogenesis, October 1, 2005; 26(10): 1731 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
O. Habi, M.-C. Delisle, N. Messier, and M. Carreau
Lack of Self-Renewal Capacity in Fancc-/- Stem Cells After Ex Vivo Expansion
Stem Cells, September 1, 2005; 23(8): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ohashi, M. Z. Zdzienicka, J. Chen, and F. J. Couch
Fanconi Anemia Complementation Group D2 (FANCD2) Functions Independently of BRCA2- and RAD51-associated Homologous Recombination in Response to DNA Damage
J. Biol. Chem., April 15, 2005; 280(15): 14877 - 14883.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. G. Howlett, T. Taniguchi, S. G. Durkin, A. D. D'Andrea, and T. W. Glover
The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability
Hum. Mol. Genet., March 1, 2005; 14(5): 693 - 701.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. H. van Beers, T. van Welsem, L. F.A. Wessels, Y. Li, R. A. Oldenburg, P. Devilee, C. J. Cornelisse, S. Verhoef, F. B.L. Hogervorst, L. J. van't Veer, et al.
Comparative Genomic Hybridization Profiles in Human BRCA1 and BRCA2 Breast Tumors Highlight Differential Sets of Genomic Aberrations
Cancer Res., February 1, 2005; 65(3): 822 - 827.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Soulier, T. Leblanc, J. Larghero, H. Dastot, A. Shimamura, P. Guardiola, H. Esperou, C. Ferry, C. Jubert, J.-P. Feugeas, et al.
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway
Blood, February 1, 2005; 105(3): 1329 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Yamamoto, S. Hirano, M. Ishiai, K. Morishima, H. Kitao, K. Namikoshi, M. Kimura, N. Matsushita, H. Arakawa, J.-M. Buerstedde, et al.
Fanconi Anemia Protein FANCD2 Promotes Immunoglobulin Gene Conversion and DNA Repair through a Mechanism Related to Homologous Recombination
Mol. Cell. Biol., January 1, 2005; 25(1): 34 - 43.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Busygina, K. Suphapeetiporn, L. R. Marek, R. S. Stowers, T. Xu, and A. E. Bale
Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1
Hum. Mol. Genet., October 1, 2004; 13(20): 2399 - 2408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Leveille, E. Blom, A. L. Medhurst, P. Bier, E. H. Laghmani, M. Johnson, M. A. Rooimans, A. Sobeck, Q. Waisfisz, F. Arwert, et al.
The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor Protein
J. Biol. Chem., September 17, 2004; 279(38): 39421 - 39430.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.